[Dementia induced by cardiokinetic and anti-hypertensive drugs].
Hirai
Shunsaku
S
Gunma University.
D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000493:pharmacokinetics; D002316:Cardiotonic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics; D003000:Clonidine / Q000009:adverse effects / Q000493:pharmacokinetics; D003704:Dementia / Q000139:chemically induced*; D004074:Digitoxin / Q000009:adverse effects / Q000493:pharmacokinetics; D004077:Digoxin / Q000009:adverse effects / Q000493:pharmacokinetics; D006207:Half-Life; D006801:Humans; D008750:Methyldopa / Q000009:adverse effects / Q000493:pharmacokinetics; D011433:Propranolol / Q000009:adverse effects / Q000493:pharmacokinetics; D012110:Reserpine / Q000009:adverse effects / Q000493:pharmacokinetics
D000959:Antihypertensive Agents; D002316:Cardiotonic Agents; D008750:Methyldopa; D004077:Digoxin; D012110:Reserpine; D011433:Propranolol; D004074:Digitoxin; D003000:Clonidine